Emergency Department-initiated Naltrexone for Alcohol Use Disorder: Association with Recidivism
Western Journal of Emergency Medicine · 16.07.2026 · 27 (4)
DOI: 10.5811/westjem.52971 ↗Kurz gefasst
Fachartikel in der Zeitschrift Western Journal of Emergency Medicine, online erschienen am 16.07.2026. Verfasst von Otis Warren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Brown University Health, Department of Emergency Medicine, Providence, Rhode Island. Hauptthemen laut MEDLINE: Naltrexone, Emergency Service, Hospital, Alcoholism, Narcotic Antagonists. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Introduction
Alcohol use disorder (AUD) contributes to significant healthcare costs, disease, emergency department (ED) crowding, and recidivism. Naltrexone is a treatment for AUD that has been approved by the U.S. Food and Drug Administration and holds promise as a pharmacologic intervention for ED patients with AUD. We hypothesized that subjects who received naltrexone in the ED would have associated reduced recidivism in the 30 days after treatment.
Methods
This was a retrospective chart review of an AUD quality program comparing ED visits in the 30 days before with 30 days after initiation of naltrexone in the ED. We performed this study at two academic hospitals (one a Level I trauma center) and one community hospital.
Results
A total of 297 subjects (median age 43 years, 69.5% male) made 331 naltrexone index visits during the study period. There was no difference in the number of ED visits before versus after the index visit among all subjects (0 median visits before [interquartile range 0-1] versus 0 median after [0-1]). Subjects who were frequent ED users (defined as ≥ 4 ED visits in the 90 days preceding (N=56 [16.9%]) had a significant reduction in ED visits after administration of naltrexone (median of 5 visits [3-8] before versus 3 [2,6] after), with 36 of these subjects (64.3%) having reduced ED visits in the 30 days after naltrexone administration.
Conclusion
Naltrexone administered in the emergency department had no associated change on the study population’s rates of recidivism for alcohol use disorder, but it was associated with reduced ED recidivism in subjects with high ED use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Brown University Health, Department of Emergency Medicine, Providence, Rhode Island.
Zitieren
APA
Warren, O., Gress, J., Lin, T., Lippmann, M., & Bubly, G. (2026). Emergency Department-initiated Naltrexone for Alcohol Use Disorder: Association with Recidivism. Western Journal of Emergency Medicine, 27(4). https://doi.org/10.5811/westjem.52971
Vancouver
Warren O, Gress J, Lin T, Lippmann M, Bubly G. Emergency Department-initiated Naltrexone for Alcohol Use Disorder: Association with Recidivism. Western Journal of Emergency Medicine. 2026;27(4). doi:10.5811/westjem.52971
BibTeX
@article{Warren2026,
author = {Warren, Otis and Gress, Jeremiah and Lin, Timmy and Lippmann, Melanie and Bubly, Gary},
title = {Emergency Department-initiated Naltrexone for Alcohol Use Disorder: Association with Recidivism},
journal = {Western Journal of Emergency Medicine},
year = {2026},
volume = {27},
number = {4},
doi = {10.5811/westjem.52971}
}
EUVIMED